CORE SCIENTIFIC INC

Weiss Eric Stanton buys 6,000 Core Scientific shares—showing steady, insider confidence in AI‑centric colocation and a cautiously optimistic outlook for the company.

Insight on Core Scientific’s insider selling: Todd M. Duchene’s Rule 10b‑5‑1 plan shows planned, modest sales that keep price stable while keeping the stock attractive for long‑term value investors.

Weiss Eric Stanton’s latest Core Scientific buy signals confidence amid volatility—an insider cue that the blockchain‑AI firm may be poised for upside.

Core Scientific insider Todd Duchene keeps selling, averaging $20‑$22 per share. Is this a strategic plan or a warning? Dive in to see what it means for investors.

Insider selling at Core Scientific: Director Duchene Todd M offloads >$200k of shares amid a pivot to AI infrastructure and a new AMD partnership—what investors should watch.

Core Scientific insider Todd DuChene sells 10k shares under a Rule 10b5‑1 plan—signal of disciplined profit‑taking amid volatile market trends. Click to learn how this may affect investor confidence and the company’s future prospects.

CEO Sullivan Adam Taylor’s July 2026 insider sale of 15,584 Core Scientific shares at $22.72 sparks investor curiosity—why now, what it signals for the stock’s future, and how it fits into a broader liquidity strategy.

Insider selling surge at Core Scientific: Todd Duchene trims 2M shares amid market decline, raising questions on short‑term confidence and potential buying opportunity.

Core Scientific insider Todd M. Duchene sells 10k shares as the stock climbs—does this signal a shift in confidence or routine liquidity? Discover the impact for investors.

Insider Todd M. Duchene’s 10,000‑share sale of Core Scientific Inc. reveals a disciplined, rule‑based liquidation amid a volatile market, offering investors insight into potential liquidity impacts while underscoring ongoing confidence in the compan…